NeuroSense Therapeutics Ltd. Gains 77.6%
Thu, Jan 19, 2023 at 06:57 PM
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) shot up at $2.22, representing a gain of 77.6%. On Thu, Jan 19, 2023, NRSN:NASDAQ hit a New 2-Week High of $2.22. The stock appeared on our News Catalysts scanner on Thu, Jan 19, 2023 at 10:27 AM in the 'EARNINGS' category. From Thu, Jan 05, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Thu, Jan 19, 2023 at $2.91 with a volume of 81M+.
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- Genius Group Limited (GNS:NYSEMKT), 290.29%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 77.6%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 54.31%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 38.35%
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 29.11%
- Sema4 Holdings Corp. (SMFR:NASDAQ), 26.78%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 23.07%
- Edible Garden AG Incorporated (EDBL:NASDAQ), 23.06%
- BeyondSpring Inc. (BYSI:NASDAQ), 23.04%
- Amesite Inc. (AMST:NASDAQ), 22.36%